NCT07509775 Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System
| NCT ID | NCT07509775 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China-Japan Friendship Hospital |
| Condition | Ankylosing Spondylitis (AS) |
| Study Type | OBSERVATIONAL |
| Enrollment | 210 participants |
| Start Date | 2026-01-19 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 210 participants in total. It began in 2026-01-19 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a multicentre, ambidirectional, observational cohort study. The ambidirectional design incorporates both the collection of retrospective data from the three years prior to enrolment, and a prospective follow-up period of up to two years. The study is designed to evaluate the long-term effects of Integrated Medicine on radiographic progression in patients diagnosed with Ankylosing spondylitis (AS).
Eligibility Criteria
Inclusion Criteria: * fulfill the 1984 modified New York criteria for ankylosing spondylitis or the 2009 Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis * age between 18 and 75 years * sign informed consent. Exclusion Criteria: * diagnosis of other autoimmune diseases besides the disease under investigation (e.g., rheumatoid arthritis, Sjögren's syndrome, erythema nodosum, myositis, etc.) * pregnancy or lactation * comorbid severe cardiovascular or cerebrovascular diseases, hepatic or renal failure, or malignancy * spondyloarthritis related to enteropathic arthritis, psoriatic arthritis, or reactive arthritis * unable to provide data due to mental, language, or similar factors.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07509775 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Ankylosing Spondylitis (AS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07509775 currently recruiting?
Yes, NCT07509775 is actively recruiting participants. Contact the research team at zyysdmn1234@163.com for enrollment information.
Where is the NCT07509775 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07509775 clinical trial?
NCT07509775 is sponsored by China-Japan Friendship Hospital. The trial plans to enroll 210 participants.